Metraipolis › archive › dc_2df92a7b995f
Discontinuation of the development of remimazolam for ICU sedation in Japan: background and rationale — Europe PMC PMID:41566504
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41566504
- DOI
- 10.1186/s40560-[numero omesso]-8
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T15:36:40.090Z
- SHA-256 of the archived text
8622d77cfc0111e164c81222a48f4f7281e6f21a9aabf638bd9c370788c1eff0- Stable URL of this page
https://metraipolis.com/documento/dc_2df92a7b995f
How to cite
Discontinuation of the development of remimazolam for ICU sedation in Japan: background and rationale — Europe PMC PMID:41566504 — Europe PMC (en), https://europepmc.org/article/MED/41566504 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2df92a7b995f (Metraipolis archive dc_2df92a7b995f, sha256 8622d77cfc0111e164c81222a48f4f7281e6f21a9aabf638bd9c370788c1eff0)
BibTeX
@misc{dc2df92a7b995f,
title = {Discontinuation of the development of remimazolam for ICU sedation in Japan: background and rationale — Europe PMC PMID:41566504},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41566504},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2df92a7b995f; sha256 8622d77cfc0111e164c81222a48f4f7281e6f21a9aabf638bd9c370788c1eff0},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41566504. Agents can read the archived copy with the MCP tool read_document.